StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)

Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%

Gilead Sciences Consolidated revenues by Quarter

Consolidated revenues — Rest of World / Other International ($M) ($M)

QuarterlyAnnual

Gilead Sciences Consolidated revenues: $876M in Q2 2026, up 4.0% from a year earlier.

Latest, Q2 2026
876
Period ended Jun 30, 2026
Change on a year earlier
+4.0%
842 in Q2 2025
History
38 quarters
Since Q1 2017
Sources
30
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-06) ↗

Reported in Form 10-Q / 10-K Segment & Geographic Information.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedConsolidated revenues — Rest of World / Other International ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026876+4.0%Form 10-Q (filed 2026-08-06) ↗
Q1 2026Mar 31, 2026889-2.8%Form 10-Q (filed 2026-05-07) ↗
Q4 2025Dec 31, 2025813-1.6%Form 10-K (filed 2026-02-24) ↗
Q3 2025Sep 30, 2025933+0.4%Form 10-Q (filed 2025-11-07) ↗
Q2 2025Jun 30, 2025842-4.2%Form 10-Q (filed 2026-08-06) ↗
Q1 2025Mar 31, 2025915+2.3%Form 10-Q (filed 2026-05-07) ↗
Q4 2024Dec 31, 2024826+8.0%Form 10-K (filed 2026-02-24) ↗
Q3 2024Sep 30, 2024929-6.4%Form 10-Q (filed 2025-11-07) ↗
Q2 2024Jun 30, 2024879+11.4%Form 10-Q (filed 2025-08-07) ↗
Q1 2024Mar 31, 2024894+8.9%Form 10-Q (filed 2025-05-07) ↗
Q4 2023Dec 31, 2023765-26.2%Form 10-K (filed 2026-02-24) ↗
Q3 2023Sep 30, 2023993-2.0%Form 10-Q (filed 2024-11-12) ↗
Q2 2023Jun 30, 2023789-6.5%Form 10-Q (filed 2024-08-08) ↗
Q1 2023Mar 31, 2023821-20.5%Form 10-Q (filed 2024-05-08) ↗
Q4 2022Dec 31, 20221,037+56.2%Form 10-K (filed 2025-02-28) ↗
Q3 2022Sep 30, 20221,013+15.0%Form 10-Q (filed 2023-11-07) ↗

Cite this data

StockData. (2026). Gilead Sciences Consolidated revenues ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/geo-rev-row

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.